Kamil K.
- Country
- Czechia
- Department
- Plicní a TBC, onkologické odd. / Dept of Pneumology and TBC, oncological
Research Overview
Data & Insights
Has run more than one trial at 0 of 122 partner sites.
Specializations
Respiratory Therapeutics
Specializes in the treatment of Chronic Obstructive Pulmonary Disease and strategies to lower severe exacerbation rates.
- Efficacy of Astegolimab in COPD management
- Impact of inhaled corticosteroid/bronchodilator combinations on lung function
- Assessment of exacerbation frequency reduction with targeted biologics
Clinical activities are centered at the Dept of Pneumology and TBC, oncological unit in Tábor.
Heart Failure Management
Focuses on therapeutic options for patients with heart failure with reduced ejection fraction and mid‑range or preserved ejection fraction.
- Use of Finerenone in HFrEF intolerant to steroidal agents
- Reduction of total heart failure events and cardiovascular death in HFmrEF/HFpEF populations
- Safety profiling of mineralocorticoid receptor antagonists in advanced heart failure
Affiliated with Nemocnice Tabor a.s. for cardiovascular research.
Integrated Cardiopulmonary Therapy
Investigates combined inhaled regimens targeting both airway obstruction and cardiopulmonary outcomes in COPD patients.
- Triple therapy with budesonide, glycopyrronium, and formoterol for severe cardiopulmonary endpoints
- Comparison of dual bronchodilator versus triple inhaled therapy on heart‑lung interactions
- Evaluation of inhaled treatment impact on cardiovascular risk markers
Research integrates pulmonology and cardiology expertise.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.